Dysregulation of the IL-10-sphingolipid metabolism axis may also contribute to pathology in other clinical conditions such as COVID-19, where aberrant IL-10 production as well as alterations in sphingolipid metabolism and signaling has been reported. Here, IL10 is linked to COVID-19.